Top Markets
Coin of the day
Cutia Therapeutics Cutia Therapeutics

Cutia Therapeutics

2487
Rank in Stocks #22318
Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a... Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a robust dermatology platform for addressing conditions affecting both the skin and scalp. Its comprehensive therapeutic scope encompasses various dermatological challenges, including medications for localized fat accumulation, advanced care for scalp disorders, treatments for a wide array of skin ailments, and topical pain management. Founded in 2019, the company's main headquarters are situated in Shanghai, China, complemented by additional offices located in Beijing, Wuxi, and Hong Kong.
Share Price
$0.24945615
Last synced: 2026-08-21
Market Cap
$90.64M
Change (1 day)
-10.14%
Change (1 year)
-79.61%
Country
CN
Trade Cutia Therapeutics (2487)

Category

P/S ratio for Cutia Therapeutics (2487)
P/S ratio as of 2026 TTM: 0
According to Cutia Therapeutics latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Cutia Therapeutics from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH